AllianceBernstein’s Clover Health Investments CLOV Stock Holding History

AllianceBernstein’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$789K	Buy	448,500 +49,700	+12%	+$169K	﹤0.01%	2502
2026 Q1	$937K	Sell	398,800 -12,100	-3%	-$26.2K	﹤0.01%	2370
2025 Q4	$966K	Sell	410,900 -5,085	-1%	-$13.9K	﹤0.01%	2359
2025 Q3	$1.27M	Buy	415,985 +5,085	+1%	+$14.5K	﹤0.01%	2233
2025 Q2	$1.15M	Buy	+410,900	New	+$1.35M	﹤0.01%	2221
2023 Q2	–	Sell	-375,800	Closed	-$318K	–	3185
2023 Q1	$318K	Hold	375,800	–	–	﹤0.01%	2751
2022 Q4	$349K	Hold	375,800	–	–	﹤0.01%	2810
2022 Q3	$639K	Hold	375,800	–	–	﹤0.01%	2525
2022 Q2	$804K	Buy	+375,800	New	+$999K	﹤0.01%	2456

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AllianceBernstein's CLOV Position: Q2 2026 in Review

AllianceBernstein increased its Clover Health Investments (CLOV) stake by 12% in Q2 2026, buying an estimated $169K and bringing the position to 448,500 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

AllianceBernstein first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. The position peaked at $1.27M in Q3 2025. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

AllianceBernstein held 448,500 shares of Clover Health Investments worth $789K as of Q2 2026.
AllianceBernstein bought 49,700 Clover Health Investments shares in Q2 2026, an estimated $169K.
Clover Health Investments made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2502 holding.
AllianceBernstein first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
AllianceBernstein's Clover Health Investments position peaked at $1.27M in Q3 2025.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.